IMMUNOCORE HLDGS ADS/1 (6YG) — Free Cash Flow Generation Index
IMMUNOCORE HLDGS ADS/1 (6YG) has a Free Cash Flow Generation Index of 0.95x as of June 2026. Free cash flow of €15.14 Million represents 1% of operating cash flow (€15.93 Million). Explore capital reinvestment ratio of IMMUNOCORE HLDGS ADS/1 to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
IMMUNOCORE HLDGS ADS/1 Free Cash Flow Generation Index (2023–2024)
Historical FCF Generation Index trend for IMMUNOCORE HLDGS ADS/1 across 2 annual periods. For the full cash flow conversion analysis, see IMMUNOCORE HLDGS ADS/1 (6YG) cash flow conversion.
Annual Free Cash Flow Generation for IMMUNOCORE HLDGS ADS/1 (2023–2024)
Year-by-year Free Cash Flow Generation Index for IMMUNOCORE HLDGS ADS/1. Check 6YG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €20.89 Million | €26.06 Million | €5.17 Million | ▲ +194.8% |
| 2023 | -0.85x | €-2.48 Million | €2.94 Million | €5.42 Million | — |